Results 101 to 110 of about 24,669 (243)
Molecular Characterization of a Patient Presumed to Have Prader-Willi Syndrome
Prader-Willi syndrome (PWS) is caused by the loss of RNA expression from an imprinted region on chromosome 15 that includes SNRPN, SNORD115, and SNORD116. Currently, there are no mouse models that faithfully reflect the human phenotype and investigations
Marina Falaleeva +7 more
doaj +1 more source
Cerebral sinus thrombosis in an infant with Prader-Willi syndrome and literature review
A full-term male neonate from a first pregnancy of two clinical non-consanguineous parents was born at 40 weeks of gestation with cesarean section.
Ilias Chatziioannidis +5 more
doaj +1 more source
Abstract This multicenter retrospective study evaluated the effectiveness and safety of highly purified cannabidiol (CBD) in 22 patients with 15q11.2‐q13.1 duplication or deletion syndromes (15q‐DDS), including 12 with 15q duplication syndrome (dup15q) and 10 with Angelman syndrome (AS). Median (interquartile range [IQR]) age at CBD initiation was 14.5
Emanuele Cerulli Irelli +14 more
wiley +1 more source
Contributing Factors of Mortality in Prader-Willi Syndrome
Prader–Willi syndrome (PWS) is a multi‐system disorder resulting from a lack of paternal gene expression in the 15q11.2‐q13 region. Using databases compiled through response questionnaires completed by families known to the Prader‐Willi Syndrome ...
J. Proffitt +7 more
semanticscholar +1 more source
The diagnosis of Prader–Willi syndrome [PDF]
Abstract: The methylation test can make the diagnosis of Prader–Willi syndrome (PWS) in approximately 99% of patients and is confirmed as a reliable, robust screening test. In a patient with PWS, methylation analysis does not provide the mechanism, for which other different genetic tests are required. Appropriate tests are available in each Australian
openaire +2 more sources
This graphical abstract illustrates the design and key findings of a randomized, open‐label, parallel‐controlled trial comparing two dietary maintenance strategies in newly diagnosed Type 2 diabetes mellitus (T2DM) patients after short‐term intensive insulin therapy (SIIT).
Xiuhong Lin +11 more
wiley +1 more source
Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2
Melanoma antigen L2 (MAGEL2 or MAGE-L2) is a member of the MAGE family of ubiquitin ligase regulators. It is maternally imprinted and often paternally deleted or mutated in the related neurodevelopmental syndromes, Prader-Willi Syndrome (PWS) and Schaaf ...
K. F. Tacer, P. R. Potts
semanticscholar +1 more source
Tactile hypo‐responsivity in autism: Examining potential for diagnostic relevance
The study reported in this paper examined the utility of a brief tactile reactivity assessment in differentiating autistic children from those with other neurodevelopmental concerns and the association between tactile responsivity, autism symptomatology, developmental level, and adaptive skills.
Girija Kadlaskar +4 more
wiley +1 more source
Prader-Willi Syndrome (PWS) is a neurodevelopmental disorder caused by loss of expression of the paternally inherited genes on chromosome 15q11.2-q13. However, the core features of PWS have been attributed to a critical interval (PWS-cr) within the 15q11.
Simona Zahova, Anthony R. Isles
doaj +1 more source
Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome
Prader-Willi syndrome (PWS) is an imprinted neurodevelopmental disease caused by a loss of paternal genes on chromosome 15q11-q13. It is characterized by cognitive impairments, developmental delay, sleep abnormalities, and hyperphagia often leading to ...
A. Adhikari +8 more
semanticscholar +1 more source

